Deltagen is a leading
provider of drug discovery tools and services to the biopharmaceutical
industry. Deltagen offers a suite of programs designed to enhance
the efficiency of drug discovery including access to biological
models as well as both small-molecule and secreted protein
drug targets. In addition, Deltagen offers extensive target validation
data in the areas of immunology and metabolic diseases.
Deltagen's products and programs have been validated by customers
and partners
such
as
Eli Lilly & Co.,
GlaxoSmithKline, Merck & Co., Millennium Pharmaceuticals and
Pfizer.
